Reading the blueprint: could Full-Genome sequencing crack Hard-to-Diagnose cases?

NCT ID NCT07718971

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study explores whether whole-genome sequencing can uncover genetic causes in adults with unexplained medical conditions. One thousand participants will provide a blood or cheek-swab sample and allow researchers to review their medical records. The goal is to see how often sequencing identifies a diagnosis and whether those results change medical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clinical whole-genome sequencing of blood or cheek-swab DNA, with optional family analysis and return of results
What this could lead to
If successful, this could show that routine genome sequencing helps diagnose previously unexplained conditions and guides more personalized medical care.
What could go wrong
The study is observational and does not test a treatment. Many participants may receive no clear genetic answer, and results may not change care for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness hereditary disease Undiagnosed Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Washington Medical Center

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.